GENE ONLINE|News &
Opinion
Blog

RNA
Orna Therapeutics Secures Multi-Billion RNA Deal With Merck After $221 Million Series B
2022-08-17
Single Cell Sequencing – the Current Players
2022-08-04
Life Began with RNA Theory Gets Renewed Support
2022-05-20
RNA Therapeutics Beyond Vaccines
2022-05-19
JPM22 Highlights: Amgen Sees Potential in Arrakis, Freenome Gets Boosted by Roche Again
2022-01-12
RNAi Player Sirnaomics Squeezes in $50 Million IPO in Hong Kong
2022-01-03
China’s Innoforce Bags $157 Million to Boost Cell, Gene and RNA CDMO Services
2021-12-10
Scientists Engineer RNA Switches for Targeted Delivery of Gene Therapy and RNA Therapeutics
2021-11-07
Current Challenges and Future Opportunities of Artificial RNA Editing – An Interview with Professor Toshifumi Tsukahara
2021-08-26
Scientists Unveil Novel Protein That Delivers Molecular Medicines to Human Cells
2021-08-25
Laronde Launches to Disrupt the Industry with Programmable Circular RNA Therapies
2021-05-15
Orna Therapeutics Brings to Market New Therapy to Treat Cancer and Other Diseases
2021-02-26
JPM Healthcare Conference: Shape, Korro, and Ionis Present Advances in RNA Therapeutics
2021-01-18
Locanabio Raises $100M to Advance CRISPR-Mediated RNA-Targeting Therapies
2020-12-18
Proximity RNA Sequencing: Breaking New Grounds in Spatial Transcriptomics
2020-06-28
1 2
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top